Skip to main content
SpringerLink
Log in

Peritoneal Dialysis Adequacy

  • Chapter
  • First Online:
Applied Peritoneal Dialysis

  • 826 Accesses

Abstract

This chapter begins by exploring the historical framework of the understanding of peritoneal dialysis adequacy. A survey of the evidence base is presented to explain the evolution of thought on the topic, with emphasis on the current appreciation of residual kidney function as an important contributor to peritoneal dialysis adequacy. It concludes with some practical recommendations related to preservation of residual kidney function as well as ways to enhance peritoneal adequacy by modifying the dialysis prescription.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Giovannetti S. Diet in chronic uremia. Clin Nephrol. 1967;3:230–6.

    Google Scholar 

  2. Scribner BH. Discussion. Trans Am Soc Artif Intern Organs. 1965;11:29.

    Google Scholar 

  3. Babb AL, Popovich RP, Christopher TG, Scribner BH. The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs. 1971;17:81–91.

    CAS  PubMed  Google Scholar 

  4. Lowrie EG, et al. Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med. 1981;305(20):1176–81.

    Article  CAS  Google Scholar 

  5. Oreopoulos DG. Beyond Kt/V: Redefining adequacy of dialysis in the 21st century. Int Urol Nephrol. 2002;34(3):393–403.

    Article  CAS  Google Scholar 

  6. Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2018;567:305–7.

    Article  Google Scholar 

  7. Sargent JA, Gotch FA. The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int. 1975;7(Suppl 2):S35–44.

    Google Scholar 

  8. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985;28:526–34.

    Article  CAS  Google Scholar 

  9. Teehan BP, Schleifer CR, Brown JM, et al. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv Perit Dial. 1990;6:181–5.

    CAS  PubMed  Google Scholar 

  10. Churchill DN, Taylor DW, Keshaviah PR, CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7:198–207.

    Article  Google Scholar 

  11. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy Am J Kidney Dis. 1997; 30(3):S67–S136.

    Google Scholar 

  12. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13:1307–20.

    Article  CAS  Google Scholar 

  13. Lo WK, Ho YW, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64(2):649–56.

    Article  Google Scholar 

  14. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. New Engl J Med. 2003;347:2010–9.

    Article  Google Scholar 

  15. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–62.

    Article  Google Scholar 

  16. Maiorca R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant. 1995;10(12):2295–305.

    Article  CAS  Google Scholar 

  17. Diaz-Buxo JA, et al. Peritoneal dialysis adequacy: a model to assess feasibility with various modalities. Kidney Int. 1999;55(6):2493–501.

    Article  CAS  Google Scholar 

  18. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003;41:1293–302.

    Article  Google Scholar 

  19. Wang AY, Woo J, Wang M, et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant. 2005;20:396–403.

    Article  Google Scholar 

  20. Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int. 2003;23:174–83.

    Article  Google Scholar 

  21. Wang AY, Wang M, Woo J, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol. 2004;15:2186–94.

    Article  CAS  Google Scholar 

  22. Pecoits-Filho R, Heimburger O, Barany P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41:1212–8.

    Article  Google Scholar 

  23. Ates K, Nergizoglu G, Keven K, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001;60:767–76.

    Article  CAS  Google Scholar 

  24. Konings CJ, Kooman JP, Schonck M, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant. 2003;18:797–803.

    Article  Google Scholar 

  25. Konings CJ, Kooman JP, Schonck M, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int. 2002;22:477–87.

    Article  Google Scholar 

  26. Bammens B, et al. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int. 2003;64(6):2238–43.

    Article  CAS  Google Scholar 

  27. Leong SC, et al. Residual function effectively controls plasma concentrations of secreted solutes in patients on twice weekly hemodialysis. J Am Soc Nephrol. 2018;29(7):992–1999.

    Article  Google Scholar 

  28. Brown EA, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol. 2003;14(11):2948–57.

    Article  Google Scholar 

  29. Konings CJ, Kooman JP, Gladziwa U, van der Sande FM, Leunissen KM. A decline in residual glomerular filtration during the use of icodextrin may be due to underhydration. Kidney Int. 2005;67:1190–1.

    Article  Google Scholar 

  30. Persson PB, Patzak A. Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration. Nephrol Dial Transplant. 2005;20(Suppl 1):i2–5.

    Article  Google Scholar 

  31. Zhao S-j, Zhong Z-s, Qi G-x, Tian W. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Int J Cardiol. 2016;221:251–9.

    Article  Google Scholar 

  32. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med. 2003;139:105–12.

    Article  CAS  Google Scholar 

  33. Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal functioning patients on CAPD. Am J Kidney Dis. 2004;43:1056–64.

    Article  CAS  Google Scholar 

  34. Davies SJ. Peritoneal dialysis in the patient with a failing renal allograft. Perit Dial Int. 2001;21(Suppl 3):S280–4.

    Article  Google Scholar 

  35. Jassal SV, et al. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. Am J Kidney Dis. 2002;40(1):178–83.

    Article  Google Scholar 

  36. Fischbach M, et al. Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume. Pediatr Nephrol. 2014;29(8):1321–7.

    Article  Google Scholar 

  37. Plum J, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis. 2002;39:862–71.

    Article  CAS  Google Scholar 

  38. Brown E et al: International society for peritoneal dialysis practice recommendations: Prescribing High Quality Goal-Directed Peritoneal dialysis. Perit Dial Int. 2020 (in press).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Toronto, Division of Nephrology, Department of Medicine, University Health Network, Toronto, ON, Canada

    Ali Z. Ibrahim

  2. Division of Nephrology, University of Toronto, University Health Network/Toronto General Hospital, Toronto, ON, Canada

    Joanne M. Bargman

Authors
  1. Ali Z. Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanne M. Bargman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Z. Ibrahim .

Editor information

Editors and Affiliations

  1. CORE Kidney Health Program, Department of Medicine, Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Anjay Rastogi

  2. University of Illinois at Chicago, College of Medicine, Chicago, IL, USA

    Edgar V. Lerma

  3. Division of Nephrology, University of Toronto, University Health Network/Toronto General Hospital, Toronto, ON, Canada

    Joanne M. Bargman

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ibrahim, A.Z., Bargman, J.M. (2021). Peritoneal Dialysis Adequacy. In: Rastogi, A., Lerma, E.V., Bargman, J.M. (eds) Applied Peritoneal Dialysis. Springer, Cham. https://doi.org/10.1007/978-3-030-70897-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70897-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70896-2

  • Online ISBN: 978-3-030-70897-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation